BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38849434)

  • 21. Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
    Duc D; Vigne S; Bernier-Latmani J; Yersin Y; Ruiz F; Gaïa N; Leo S; Lazarevic V; Schrenzel J; Petrova TV; Pot C
    Cell Rep; 2019 Oct; 29(2):378-390.e4. PubMed ID: 31597098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
    Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet.
    Duhen R; Glatigny S; Arbelaez CA; Blair TC; Oukka M; Bettelli E
    J Immunol; 2013 May; 190(9):4478-82. PubMed ID: 23543757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
    Jäger A; Dardalhon V; Sobel RA; Bettelli E; Kuchroo VK
    J Immunol; 2009 Dec; 183(11):7169-77. PubMed ID: 19890056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
    Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A
    J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.
    Maria Z; Turner E; Agasing A; Kumar G; Axtell RC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
    Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
    J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-9-triggered lncRNA Gm13568 regulates Notch1 in astrocytes through interaction with CBP/P300: contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Liu X; Zhou F; Wang W; Chen G; Zhang Q; Lv R; Zhao Z; Li X; Yu Q; Meves JM; Hua H; Li X; Wang X; Sun H; Gao D
    J Neuroinflammation; 2021 May; 18(1):108. PubMed ID: 33971906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
    Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
    J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
    Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
    Pennell LM; Fish EN
    Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism.
    Prado DS; Damasceno LEA; Sonego AB; Rosa MH; Martins TV; Fonseca MDM; Cunha TM; Cunha FQ; Alves-Filho JC
    Int Immunopharmacol; 2021 Feb; 91():107278. PubMed ID: 33341737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease.
    Tsai VW; Mohammad MG; Tolhurst O; Breit SN; Sawchenko PE; Brown DA
    J Neurosci; 2011 Nov; 31(48):17612-21. PubMed ID: 22131422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; O'Brien K; Young A; Fonseca-Kelly Z; Rostami A; Gran B
    J Neuroinflammation; 2014 Jul; 11():130. PubMed ID: 25069698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
    J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.